Αποτελέσματα Αναζήτησης
16 Απρ 2023 · The most common benign cause is PHPT, where patients are usually asymptomatic and have a long-standing history of mild hypercalcemia. Serum calcium levels greater than 13 mg/dL on initial presentation should raise suspicion of malignancy as the cause of hypercalcemia.
21 Σεπ 2018 · This article reviews the causes of hypercalcemia in the patient with cancer and describes the diagnostic steps and treatment options for the most common causes of hypercalcemia. Many organs are involved in the regulation of calcium.
Higher than normal levels of calcium in the blood. Some types of cancer increase the risk of hypercalcemia. ICD-10-CM E83.52 is grouped within Diagnostic Related Group (s) (MS-DRG v42.0): 640 Miscellaneous disorders of nutrition, metabolism, fluids and electrolytes with mcc.
Hypercalcemia of malignancy is a common finding typically found in patients with advanced stage cancers. We aimed to provide an updated review on the etiology, pathogenesis, clinical presentation, and management of malignancy-related hypercalcemia.
Hypercalcemia can occur in those with malignancy and an additional etiology for hypercalcemia such as primary hyperparathyroidism or granulomatous diseases. This paper reviews the cancers associated with hypercalcemia and their proposed mechanisms, nontumor-mediated hypercalcemia, as well as diagnosis and treatment strategies for each condition.
The most common form (approximately 80% of all cases) is humoral hypercalcemia caused by the production of parathyroid hormone-related peptide (PTHrP). The next most frequent cause is bone metastases (osteolytic hypercalcemia), which account for approximately 20% of hypercalcemia in cancer.
13 Απρ 2022 · Hypercalcemia frequently complicates the care of patients with cancer, occurring in up to 30% of such patients during the course of their disease. 1 Hypercalcemia has been reported in association...
